PIN33 COST EFFECTIVENESS OF SWITCHING TO SECOND LINE THERAPY WITH LOPINAVIR/RITONAVIR (LPV/R) IN KENYA
May 1, 2009, 00:00
10.1016/S1098-3015(10)73641-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)73641-X/fulltext
Title :
PIN33 COST EFFECTIVENESS OF SWITCHING TO SECOND LINE THERAPY WITH LOPINAVIR/RITONAVIR (LPV/R) IN KENYA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73641-X&doi=10.1016/S1098-3015(10)73641-X
First page :
Section Title :
Open access? :
No
Section Order :
95